Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Texting your doctor: a simple app could save lives after lung screening

NCT ID NCT07234929

First seen Nov 19, 2025 · Last updated Jun 22, 2026 · Updated 35 times

Summary

This study tests whether using a chat-based mobile app (Zalo) can help people follow through with recommended tests after an abnormal chest X-ray read by AI. About 2,692 adults in Vietnam at risk for lung cancer or TB will be randomly assigned to receive either standard results or extra chat-based guidance and doctor access. The goal is to see if digital support boosts follow-up rates and speeds up diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS (TB) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nhan Dan Gia Dinh Hospital

    Ho Chi Minh City, Ho Chi Minh City, 700000, Vietnam

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

chat-based mobile application (Zalo) for consultation and education

What this could lead to

If successful, this could provide a low-cost, scalable way to improve follow-up after lung disease screening, leading to earlier diagnosis and treatment of lung cancer and TB.

What could go wrong

This is a single-center trial in Vietnam, so results may not apply elsewhere. It relies on patients having a smartphone and Zalo account, and compliance is self-reported, which may be inaccurate.

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm Patient Compliance tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.